Babraham Institute Joins Alliance for European Excellence and Competitiveness in Life Science

Babraham Institute Joins Alliance for European Excellence and Competitiveness in Life Science

The Babraham Institute has recently joined an alliance of 13 top European research centres in life sciences to foster excellence in research, share knowledge and influence policy.  Partners in the alliance, called EU-LIFE, are renowned research centres that operate with similar principles of excellence, external reviews, independence, competitiveness and internationality.  During difficult economic times and within a highly competitive research landscape, they believe that they can join forces to better address complex questions, thereby contributing to pushing European science forward.

85 EU-LIFE members (including 8 from the Babraham Institute) recently attended two EU-LIFE events at the Centre for Genomic Regulation (CRG) in Barcelona: The first EU-LIFE Scientific Workshop on the Biology of Cancer, and the second EU-LIFE community meeting.  The EU-LIFE scientific workshop brought together basic scientists and clinicians from EU-LIFE institutes (and collaborators) to explore and discuss new directions in cancer biology.  During the second community meeting, Institute representatives joined working groups on Grants, Science Communication, Translational Research, Technology Transfer, Training, Information Technology and Indicators of Excellence (Strategy), to share best practice and benefit from each other’s expertise and experience in these domains.

Current partners of this alliance are the co-leaders Center for Genomic Regulation (CRG, Spain) and VIB (Belgium), the Institut Curie (France), the Max Delbrück Center for Molecular Medicine (MDC Berlin-Buch, Germany), Instituto Gulbenkian de Ciência (IGC,Portugal), Research Center for Molecular Medicine of the Austrian Academy of Sciences (CeMM, Austria), the European Institute of Oncology (IEO, Italy), the Central European Institute of Technology (CEITEC, Czech Republic), the Netherlands Cancer Institute (Netherlands), the Institute for Molecular Medicine Finland (FIMM, Finland), the Biotech Research and Innovation Centre (BRIC, Denmark), the Babraham Institute (United Kingdom), the Friedrich Miescher Institute for Biomedical Research (FMI, Switzerland).

Contact details:
The Knowledge Exchange Office
Tel:       +44 (0)1223 496206

The Babraham Institute
Babraham Research Campus
Cambridge CB22 3AT
​United Kingdom
Notes to Editors:
About the Babraham Institute:
The Babraham Institute undertakes world-class life sciences research to generate new knowledge of biological mechanisms underpinning ageing, development and the maintenance of health. Our research focuses on cellular signalling, gene regulation and the impact of epigenetic regulation at different stages of life. By determining how the body reacts to dietary and environmental stimuli and manages microbial and viral interactions, we aim to improve wellbeing and support healthier ageing. The Institute is strategically funded by the Biotechnology and Biological Sciences Research Council (BBSRC), part of UK Research and Innovation, through an Institute Core Capability Grant and also receives funding from other UK research councils, charitable foundations, the EU and medical charities.
The Biotechnology and Biological Sciences Research Council (BBSRC) is the UK funding agency for research in the life sciences. Sponsored by Government, BBSRC annually invests around £450 million in a wide range of research that makes a significant contribution to the quality of life for UK citizens and supports a number of important industrial stakeholders including the agriculture, food, chemical, health and well-being and pharmaceutical sectors. BBSRC carries out its mission by funding internationally competitive research, providing training in the biosciences, fostering opportunities for knowledge transfer and innovation and promoting interaction with the public and other stakeholders on issues of scientific interest in universities, centres and institutes.